1. Home
  2. |Professionals
  3. |Samuel Holland Edwards

Samuel Holland Edwards

Partner
Partner
c2Vkd2FyZHNAY3Jvd2VsbC5jb20=
VCard
VCard

Areas of Focus

Overview

Sam Edwards concentrates his practice in corporate and securities law, with a strong focus on emerging technologies, particularly with regard to decarbonization and the transition to clean energy.

The core of Sam’s practice is ECVC work, representing emerging companies from pre-formation through exit, and advising venture funds with portfolio company investments. He advises start-up companies with choice of entity and initial formation, SAFE, Note, and Preferred Stock financings, corporate governance, commercial matters, and exit transactions.

Sam also advises companies on a range of strategic transactions, including M&A, private financings, restructurings and recapitalizations, complex commercial agreements, and joint ventures. For clients engaged in decarbonization, clean energy, and climate technologies, he brings a deep knowledge of the current efforts to transform the energy industry, including the Inflation Reduction Act and other government programs.

Career & Education

|

    • Harvard University, B.A., cum laude, 2002
    • University of Virginia School of Law, J.D., Editorial Board, Virginia Law Review, Order of the Coif, 2005
    • Harvard University, B.A., cum laude, 2002
    • University of Virginia School of Law, J.D., Editorial Board, Virginia Law Review, Order of the Coif, 2005

    • Colorado
    • Colorado

  • Professional Activities and Memberships

    • American Bar Association, Member 
    • Colorado Bar Association, Member 
    • Denver Bar Association, Member
    • The Connie Burwell White and William W. White Foundation, Trustee, 2014 – Present 
    • More Than Me, Director, 2017 
    • Mill Levy Oversight Committee, Board Member, 2013 – 2014

    Professional Activities and Memberships

    • American Bar Association, Member 
    • Colorado Bar Association, Member 
    • Denver Bar Association, Member
    • The Connie Burwell White and William W. White Foundation, Trustee, 2014 – Present 
    • More Than Me, Director, 2017 
    • Mill Levy Oversight Committee, Board Member, 2013 – 2014

Samuel's Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights

Representative Matters

Emerging Company and Venture Capital

  • Representation of a low-carbon cement company in its Series A financing.
  • Representation of private hydrogen company in its Series A financing.
  • Representation of a health-focused consumer products company in its Series Seed, Series A, and follow-on financings.
  • Representation of a microgrid company in a preferred unit financing.
  • Representation of a cybersecurity company in its Series C and Series D financings.
  • Representation of an Israeli venture capital fund in connection with its U.S. venture investments.
  • Representation of an information security software company in a Series A financing and spin-off transaction.
  • Representation of a workforce management software company in a reorganization merger and Series A financing.

Energy

  • Representation of a low carbon cement company in connection with development of its pilot plant and related offtake arrangements.
  • Representation of low-carbon carbon black manufacturing company in all stages of the development of its initial project, including entity formation, land acquisition, permitting, fuel and electricity supply agreements, equipment and services agreements, and byproduct sales.
  • Representation of a microgrid developer in connection with negotiation of an equity line of credit and all aspects of project development.
  • Representation of a distributed solar company in a strategic debt and equity investment.
  • Representation of the developer of a Canadian liquefied natural gas terminal in an equity financing with U.S. investors.

Samuel's Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights

Practices

Samuel's Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights